126 - 150 of 8112 Results
Title
Year
- Discordance Between Balance Ability and Perception Is Associated With Falls in Parkinson’s Disease: A Coordinated Analysis2024RESTRICTEDTitle: Discordance Between Balance Ability and Perception Is Associated With Falls in Parkinson’s Disease: A Coordinated AnalysisJournal Name: Neurorehabilitation and Neural RepairPublisher: SAGE PublicationsVol: 39Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1177/15459683241300456Citation Count: 1
- Enhanced Parkin-mediated mitophagy mitigates adverse left ventricular remodelling after myocardial infarction: role of PR-3642024OPENTitle: Enhanced Parkin-mediated mitophagy mitigates adverse left ventricular remodelling after myocardial infarction: role of PR-364Journal Name: European Heart JournalPublisher: Oxford University Press (OUP)Vol: 46Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/eurheartj/ehae782Citation Count: 2
- Incorporating label uncertainty during the training of convolutional neural networks improves performance for the discrimination between certain and inconclusive cases in dopamine transporter SPECT2024OPENTitle: Incorporating label uncertainty during the training of convolutional neural networks improves performance for the discrimination between certain and inconclusive cases in dopamine transporter SPECTJournal Name: European Journal of Nuclear Medicine and Molecular ImagingPublisher: Springer Science and Business Media LLCVol: 52Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00259-024-06988-0Citation Count: 0
- Associations of motor and neuropsychiatric symptoms with comorbidities in prodromal Parkinson’s disease2024OPENTitle: Associations of motor and neuropsychiatric symptoms with comorbidities in prodromal Parkinson’s diseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2024.1452766Citation Count: 0
- Brain-derived and in vitro-seeded alpha-synuclein fibrils exhibit distinct biophysical profiles2024OPENTitle: Brain-derived and in vitro-seeded alpha-synuclein fibrils exhibit distinct biophysical profilesJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.92775.3Citation Count: 1
- The Parkinson’s disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neurons2024RESTRICTEDTitle: The Parkinson’s disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neuronsJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 19Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-024-00779-9Citation Count: 3
-
OPENTitle: A multi-region single nucleus transcriptomic atlas of Parkinson’s diseaseJournal Name: Scientific DataPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41597-024-04117-yCitation Count: 0
- Benchmarking of a multi‐biomarker low‐volume panel for Alzheimer's disease and related dementia research2024OPENTitle: Benchmarking of a multi‐biomarker low‐volume panel for Alzheimer's disease and related dementia researchJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 21Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.14413Citation Count: 3
- A Highly-Efficient, Scalable Pipeline for Fixed Feature Extraction from Large-Scale High-Content Imaging Screens2024OPENTitle: A Highly-Efficient, Scalable Pipeline for Fixed Feature Extraction from Large-Scale High-Content Imaging ScreensJournal Name: iSciencePublisher: Elsevier BVVol: 27Issue #: 12Start Page: 111434End Page: 111434Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1016/j.isci.2024.111434Citation Count: 0
- Exome sequencing in Asian populations identifies low-frequency and rare coding variation influencing Parkinson’s disease risk2024OPENTitle: Exome sequencing in Asian populations identifies low-frequency and rare coding variation influencing Parkinson’s disease riskJournal Name: Nature AgingPublisher: Springer Science and Business Media LLCVol: 5Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s43587-024-00760-7Citation Count: 3
- Genome Aggregation Database Version 4—Allele Frequency Changes and Impact on Variant Interpretation in Dystonia2024OPENTitle: Genome Aggregation Database Version 4—Allele Frequency Changes and Impact on Variant Interpretation in DystoniaJournal Name: Movement DisordersPublisher: WileyVol: 40Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.30066Citation Count: 0
- Longitudinal decline in DAT binding in Parkinson’s disease: connections with sleep disturbances2024OPENTitle: Longitudinal decline in DAT binding in Parkinson’s disease: connections with sleep disturbancesJournal Name: BMC MedicinePublisher: Springer Science and Business Media LLCVol: 22Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1186/s12916-024-03766-5Citation Count: 0
- High‐molecular‐weight oligomer tau (HMWoTau) species are dramatically increased in Braak‐stage dependent manner in the frontal lobe of human brains, demonstrated by a novel oligomer Tau ELISA with a mouse monoclonal antibody (APNmAb005)2024OPENTitle: High‐molecular‐weight oligomer tau (HMWoTau) species are dramatically increased in Braak‐stage dependent manner in the frontal lobe of human brains, demonstrated by a novel oligomer Tau ELISA with a mouse monoclonal antibody (APNmAb005)Journal Name: The FASEB JournalPublisher: WileyVol: 38Issue #: 22Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1096/fj.202401704rCitation Count: 0
- Reduced striatal M4-cholinergic signaling following dopamine loss contributes to parkinsonian and l -DOPA–induced dyskinetic behaviors2024RESTRICTEDTitle: Reduced striatal M4-cholinergic signaling following dopamine loss contributes to parkinsonian and l -DOPA–induced dyskinetic behaviorsJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 10Issue #: 47Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/sciadv.adp6301Citation Count: 1
-
OPENTitle: Dopaminergic PET to SPECT domain adaptation: a cycle GAN translation approachJournal Name: European Journal of Nuclear Medicine and Molecular ImagingPublisher: Springer Science and Business Media LLCVol: 52Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00259-024-06961-xCitation Count: 2
- Rapid modulation of striatal cholinergic interneurons and dopamine release by satellite astrocytes2024OPENTitle: Rapid modulation of striatal cholinergic interneurons and dopamine release by satellite astrocytesJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41467-024-54253-7Citation Count: 0
-
OPENTitle: A worldwide study of subcortical shape as a marker for clinical staging in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00825-9Citation Count: 0
- Circulating blood circular RNA in Parkinson’s Disease; from involvement in pathology to diagnostic tools in at-risk individuals2024OPENTitle: Circulating blood circular RNA in Parkinson’s Disease; from involvement in pathology to diagnostic tools in at-risk individualsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41531-024-00839-3Citation Count: 0
-
OPENTitle: Preferences regarding Disclosure of Risk for Parkinson's Disease in a Population‐based StudyJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 12Issue #: 2Start Page: 203End Page: 209Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mdc3.14264Citation Count: 0
- Relative sparing of dopaminergic terminals in the caudate nucleus is a feature of rest tremor in Parkinson’s disease2024OPENTitle: Relative sparing of dopaminergic terminals in the caudate nucleus is a feature of rest tremor in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41531-024-00818-8Citation Count: 0
- Peripheral immune cell abundance differences link blood mitochondrial DNA copy number and Parkinson’s disease2024OPENTitle: Peripheral immune cell abundance differences link blood mitochondrial DNA copy number and Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00831-xCitation Count: 1
- The effects of chemogenetic targeting of serotonin-projecting pathways on L-DOPA-induced dyskinesia and psychosis in a bilateral rat model of Parkinson’s disease2024OPENTitle: The effects of chemogenetic targeting of serotonin-projecting pathways on L-DOPA-induced dyskinesia and psychosis in a bilateral rat model of Parkinson’s diseaseJournal Name: Frontiers in Neural CircuitsPublisher: Frontiers Media SAVol: 18Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fncir.2024.1463941Citation Count: 0
- Large‐scale deep proteomic analysis in Alzheimer's disease brain regions across race and ethnicity2024OPENTitle: Large‐scale deep proteomic analysis in Alzheimer's disease brain regions across race and ethnicityJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 20Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/alz.14360Citation Count: 6
- PathogenicLRRK2mutations cause loss of primary cilia and Neurturin in striatal parvalbumin interneurons2024OPENTitle: PathogenicLRRK2mutations cause loss of primary cilia and Neurturin in striatal parvalbumin interneuronsJournal Name: Life Science AlliancePublisher: Life Science Alliance, LLCVol: 8Issue #: 1Start Page: e202402922End Page: e202402922Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.26508/lsa.202402922Citation Count: 1
- Gut Microbial Metabolites and Future Risk of Parkinson's Disease: A Metabolome‐Wide Association Study2024OPENTitle: Gut Microbial Metabolites and Future Risk of Parkinson's Disease: A Metabolome‐Wide Association StudyJournal Name: Movement DisordersPublisher: WileyVol: 40Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.30054Citation Count: 0